Return to search

GPP invests in JPA

Great Point Partners has invested in JPA Health, a provider of strategic and creative services for the healthcare industry.

Great Point Partners has invested in JPA Health, a provider of strategic and creative services for the healthcare industry. No financial terms were disclosed.

PRESS RELEASE

GREENWICH, CONN. AND WASHINGTON (PRWEB) MAY 04, 2022
Today Great Point Partners (“GPP”), a Greenwich-based private investment firm focused on the health care industry, announced the growth recapitalization of JPA Health (“JPA” or the “Company”). JPA is a high growth and leading public relations, marketing, and patient advocacy firm, providing strategic and creative services across the health care industry. The Company was founded in 2007 by Carrie Jones, its Chief Executive Officer. The Company is headquartered in Washington D.C., with offices in Boston, New York, and London, and has more than 90 employees.

JPA has been recognized for its outstanding marketing campaign efforts across the life sciences and public health sectors.

“Carrie and the entire JPA team have done an extraordinary job serving their clients with best-in-class insights and responsiveness,” said Bret Tenenhaus, Principal at GPP. “We look forward to helping them expand their services by facilitating add-on acquisitions and partnerships in strategic, complementary services.”

“Our clients are increasingly relying on multi-disciplinary practices to achieve their goals. With our team of specialists, we synchronize insights, ideas and incredible execution for results that impress,” said Carrie Jones, CEO at JPA Health. “Building upon our expertise in the space and unparalleled commitment to client service, we are well positioned to expand as an integrated agency attracting the best talent in the sector.”

About Great Point Partners
Great Point Partners, founded in 2003 and based in Greenwich, CT, is a leading health care investment firm with 30 professionals, investing in the United States, Canada, and Western Europe. GPP is currently making new minority and majority private equity investments from GPP III. Great Point manages $1.2B of capital (including GPP IV which has been closed but not been activated) in its private funds and public life sciences equity strategy (BioMedical Value Fund). Great Point Partners has provided growth equity, growth recapitalization, and management buyout financing to more than 200 growing health care companies. The private equity funds invest across all sectors of the health care industry with a particular emphasis on biopharmaceutical services and supplies, alternate site care, medical device and information technology enabled businesses. The firm pursues a proactive and proprietary approach to sourcing investments and tuck-in acquisitions for its portfolio companies.

About JPA
JPA Health is an award-winning independent, full-service agency established in 2007. With offices in the U.S. and UK, the agency provides marketing, public relations and advocacy services. JPA Health works with many of the world’s leading healthcare companies, NGOs and federal government agencies. The firm is a leader in the health sector recognized for its work designing health campaigns that drive change and deliver measurable results. The JPA Health team is passionate about helping people live healthier lives. To learn more, visit http://www.jpa.com.